Clincosm LogoSign in Get a demo

Vincere Biobank Research Protocol

Sponsor
Vincere Cancer Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05954299
Collaborator
(none)
5,000
Enrollment
1
Location
185.5
Anticipated Duration (Months)
27
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The Vincere Biobank aims to make quality biospecimens and associated clinical data available for research studies related to advancing medicine and improving care for patients, including cancer screening, treatment, and care.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    5000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Vincere Biobank Research Protocol
    Anticipated Study Start Date :
    Jul 17, 2023
    Anticipated Primary Completion Date :
    Dec 31, 2033
    Anticipated Study Completion Date :
    Dec 31, 2038

    Arms and Interventions

    Arm Intervention/Treatment
    Normal

    Participants and donor samples without disease (ex: non-cancer)
    Disease state or condition

    Participants and donor samples with known disease or condition (ex: cancer)

    Outcome Measures

    Primary Outcome Measures

    1. Biobank [10 years]

      Collect quality biospecimens with associated clinical data for research studies related to improving medicine and care to the patient, including cancer screening, treatment, and care.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • 18 years of age or older; any gender

    • Able to donate a blood, urine, tissue, and/or other biospecimen sample

    • Able to provide informed consent to participate in the study

    Exclusion Criteria:

    • Minors, under the age of 18 years

    • Individuals who lack the capacity to give informed consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Vincere Cancer Center Scottsdale Arizona United States 85260

    Sponsors and Collaborators

    • Vincere Cancer Center

    Investigators

    • Principal Investigator: Vershalee Shukla, MD, Vincere Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Vincere Cancer Center
    ClinicalTrials.gov Identifier:
    NCT05954299
    Other Study ID Numbers:
    • VCC-BIOBANK-001
    First Posted:
    Jul 20, 2023
    Last Update Posted:
    Jul 20, 2023
    Last Verified:
    Jul 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Vincere Cancer Center
    Cancer
    Biobank
    Biorepository

    Study Results

    No Results Posted as of Jul 20, 2023